Immediate Impact
25 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
2024 Standout
Works of NL Busaidy being referenced
Phase II trial of sunitinib in medullary thyroid cancer (MTC).
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| NL Busaidy | 53 | 10 | 18 | 30 | 2 | 65 | |
| Takayuki Okuji | 19 | 7 | 20 | 39 | 4 | 65 | |
| George Alexiadis | 15 | 10 | 10 | 28 | 5 | 69 | |
| Rajesh Rawal | 26 | 19 | 4 | 17 | 3 | 75 | |
| Judy Hoffman-Bolton | 8 | 14 | 18 | 37 | 3 | 63 | |
| Dan Rosmarin | 75 | 58 | 13 | 32 | 4 | 168 | |
| Paolo Delrio | 17 | 7 | 7 | 20 | 3 | 48 | |
| John Hornell | 63 | 5 | 75 | 22 | 5 | 164 | |
| Graeme P. Williams | 40 | 33 | 9 | 27 | 3 | 177 | |
| Tobias Suske | 13 | 3 | 19 | 11 | 3 | 60 | |
| Joe Germino | 29 | 6 | 4 | 38 | 5 | 174 |
All Works
Loading papers...